FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2534348569> ?p ?o ?g. }

• W2534348569 abstract "Abstract Abstract 1383 Explorative genome-wide next-generation sequencing of leukaemias and lymphomas has revealed a wide spectrum of acquired mutations and considerable tumour heterogeneity that might be responsible for disease initiation, resistance to treatments and relapse. There is, therefore, a clinical need to identify these genetic abnormalities in a diagnostic setting. Here, we present the development and validation of a targeted next generation mutation analysis tool. To compare the distribution pattern of genetic abnormalities in chronic lymphocytic leukemia (CLL), we performed targeted deep sequencing on CLL samples using a TruSeq custom designed targeted amplicon assay (TSCA, Illumina). We reveal differential mutation distribution patterns depending on clinical CLL subgroups. The TSCA panel was designed to amplify 21 genes (table 1) with known or suspected links to either the development of CLL or as response predictors, including TP53, SF3B1 (Puente, Nature, 2011; Quesada et al, 2012) and NOTCH1 (Rossi, Blood, 2012). Where genes have known mutational hotspots in CLL, only these regions were included in our panel, for example exons 5–8 of TP53. For genes such as MAP2K1, where mutations are distributed throughout the coding region, every exon was targeted. In total, we were able to design an amplicon panel able to cover 99% of our desired 36,035bp target region. Table 1. List of genes included in CLL custom amplicon panel ASXL1 ATM CHD2 DDX3X FBXW7 HMCN1 IRF4 KLHL6 LRP1B MAP2K1 MAPK1 MED12 NOTCH1 PCLO POT1 SAMHD1 SF3B1 TP53 XPO1 ZFPM2 ZMYM3 In order to validate our approach, we used samples previously subjected to whole genome sequencing as controls. Of the 13 individual mutations in the control cohort, we were successfully able to detect 10 (77%) with our custom assay to an average depth of 1380x. A 19bp deletion in TP53 failed to be picked up by the variant calling software, and 2 point mutations in ATM were not detected due to the targeted nature of the assay. There was a single false positive mutation across all samples in ZFPM2, caused by a sequencing error in a homopolymer region. The sample group consisted of 45 representative CLL cases, split into two cohorts. The first cohort consisted of 11 cases that have yet to receive any treatment, whilst the second cohort comprised 34 relapsed/refractory cases. Analysis of further samples is in progress. We performed library preparation according to the manufacturers instructions. Each sample was dual indexed with two 8bp “barcodes” prior to equimolar pooling, and the final pooled library was processed on an Illumina MiSeq instrument using the TruSeq 2×150bp paired end sequencing protocol. The run produced 1.6Gb of passed filter sequence data, with 92.8% of above the quality threshold of Q30. The average depth of coverage across all samples was 849x. Primary analysis of the sequencing data was performed using the cloud based data analysis package from Illumina, which carried out the alignment and variant calling. A conservative quality score threshold of >99 was set, with all variants above this carried forward for further analysis. Our custom amplicon panel detected mutations in 35 of the samples, comprising 8 indels and 45 point mutations. Of the 54 mutations, 40 were missense, 8 were frame-shifts, 1 was a nonsense mutation and 5 are predicted to have functional effects on splicing domains. The most frequently mutated gene was TP53, followed by SF3B1, PCLO and NOTCH1 (figure 1). Fig 1 Frequency of genes with somatic mutations in our CLL cohort. Fig 1. Frequency of genes with somatic mutations in our CLL cohort. Importantly, there was good correlation between mutation allele frequencies from whole genome sequencing, targeted deep sequencing and TSCA, demonstrating that the high sensitivity of large-scale genome sequencers can be reliably applied in a diagnostic setting. We describe mutation hotspots and mutation distribution patterns and link them to clinical behaviour. For example: SF3B1 mutations occurred in 15% of patients and were linked to reduced progression free survival. In conclusion, our technique allows for rapid mutation detection of the most frequently mutated genes in CLL. Further refinements in amplicon design and variant calling will lead to added precision. TSCA design and validation for other haematological diseases is in progress. Disclosures: No relevant conflicts of interest to declare." @default.
• W2534348569 created "2016-10-28" @default.
• W2534348569 creator A5016957205 @default.
• W2534348569 creator A5020152756 @default.
• W2534348569 creator A5045598167 @default.
• W2534348569 creator A5059876373 @default.
• W2534348569 creator A5063199872 @default.
• W2534348569 creator A5085504983 @default.
• W2534348569 creator A5089630665 @default.
• W2534348569 date "2012-11-16" @default.
• W2534348569 modified "2023-09-28" @default.
• W2534348569 title "Targeted Gene Profiling Identifies Differential Genetic Make-up Depending On Chronic Lymphocytic Leukaemia Subtype" @default.
• W2534348569 doi "https://doi.org/10.1182/blood.v120.21.1383.1383" @default.
• W2534348569 hasPublicationYear "2012" @default.
• W2534348569 type Work @default.
• W2534348569 sameAs 2534348569 @default.
• W2534348569 citedByCount "0" @default.
• W2534348569 crossrefType "journal-article" @default.
• W2534348569 hasAuthorship W2534348569A5016957205 @default.
• W2534348569 hasAuthorship W2534348569A5020152756 @default.
• W2534348569 hasAuthorship W2534348569A5045598167 @default.
• W2534348569 hasAuthorship W2534348569A5059876373 @default.
• W2534348569 hasAuthorship W2534348569A5063199872 @default.
• W2534348569 hasAuthorship W2534348569A5085504983 @default.
• W2534348569 hasAuthorship W2534348569A5089630665 @default.
• W2534348569 hasConcept C104317684 @default.
• W2534348569 hasConcept C120599132 @default.
• W2534348569 hasConcept C2777938653 @default.
• W2534348569 hasConcept C2778461978 @default.
• W2534348569 hasConcept C2993206177 @default.
• W2534348569 hasConcept C36823959 @default.
• W2534348569 hasConcept C42062724 @default.
• W2534348569 hasConcept C49105822 @default.
• W2534348569 hasConcept C54355233 @default.
• W2534348569 hasConcept C70721500 @default.
• W2534348569 hasConcept C8185291 @default.
• W2534348569 hasConcept C86803240 @default.
• W2534348569 hasConceptScore W2534348569C104317684 @default.
• W2534348569 hasConceptScore W2534348569C120599132 @default.
• W2534348569 hasConceptScore W2534348569C2777938653 @default.
• W2534348569 hasConceptScore W2534348569C2778461978 @default.
• W2534348569 hasConceptScore W2534348569C2993206177 @default.
• W2534348569 hasConceptScore W2534348569C36823959 @default.
• W2534348569 hasConceptScore W2534348569C42062724 @default.
• W2534348569 hasConceptScore W2534348569C49105822 @default.
• W2534348569 hasConceptScore W2534348569C54355233 @default.
• W2534348569 hasConceptScore W2534348569C70721500 @default.
• W2534348569 hasConceptScore W2534348569C8185291 @default.
• W2534348569 hasConceptScore W2534348569C86803240 @default.
• W2534348569 hasLocation W25343485691 @default.
• W2534348569 hasOpenAccess W2534348569 @default.
• W2534348569 hasPrimaryLocation W25343485691 @default.
• W2534348569 hasRelatedWork W2012611620 @default.
• W2534348569 hasRelatedWork W2095329844 @default.
• W2534348569 hasRelatedWork W2098005556 @default.
• W2534348569 hasRelatedWork W2154535522 @default.
• W2534348569 hasRelatedWork W2261716217 @default.
• W2534348569 hasRelatedWork W2282752578 @default.
• W2534348569 hasRelatedWork W2285152952 @default.
• W2534348569 hasRelatedWork W2463071333 @default.
• W2534348569 hasRelatedWork W2468763159 @default.
• W2534348569 hasRelatedWork W2568003672 @default.
• W2534348569 hasRelatedWork W2575768644 @default.
• W2534348569 hasRelatedWork W2578324737 @default.
• W2534348569 hasRelatedWork W2580412671 @default.
• W2534348569 hasRelatedWork W2591464408 @default.
• W2534348569 hasRelatedWork W2597155239 @default.
• W2534348569 hasRelatedWork W2763347431 @default.
• W2534348569 hasRelatedWork W2979931440 @default.
• W2534348569 hasRelatedWork W3166459253 @default.
• W2534348569 hasRelatedWork W3183006041 @default.
• W2534348569 hasRelatedWork W2511795225 @default.
• W2534348569 isParatext "false" @default.
• W2534348569 isRetracted "false" @default.
• W2534348569 magId "2534348569" @default.
• W2534348569 workType "article" @default.